Omega-3 intake counteracts symptoms of anxiety and depression in mice

Original Article ↗ Hacker News Discussion ↗

Existing human evidence & effectiveness

  • Commenters note that omega-3’s effects on depression/anxiety have already been studied in humans.
  • Summaries referenced: fish oil shows moderate improvement for major depression, small for anxiety; more benefit as an adjunct to antidepressants than alone.
  • Some stress that a “moderate” effect size is actually quite meaningful among supplements.

Mechanisms, EPA vs DHA, omega-3 vs omega-6

  • Several posts argue “omega-3” is too vague; EPA and DHA have distinct roles, with EPA often linked to antidepressant effects.
  • Some discuss endocannabinoids: omega‑6–derived ones being more THC‑like (glutamate‑increasing, potentially anxiety/psychosis‑promoting) and omega‑3–derived more CBD‑like (GABA‑increasing, potentially anxiolytic).
  • Others emphasize overall omega‑3:omega‑6 ratio, with too much omega‑6 (e.g., vegetable oils) alleged to worsen anxiety or inflammation.

Supplements vs dietary sources & quality concerns

  • Repeated concern that many omega‑3 supplements are low quality, rancid, or underdosed; “wild west” market.
  • Some argue fish/seafood and possibly algae are preferable to pills due to co‑factors and better evidence.
  • Cod liver oil is popular but raises concerns about pollutants, processing, and excess vitamin A/D.
  • A few brands are mentioned as “well‑tested,” but no consensus.

Dosing, safety, and side effects

  • High-dose omega‑3 (grams per day) is said in some comments to potentially cause arrhythmias or increase AFib/stroke risk; at least one person reports dose‑dependent palpitations.
  • Interactions with antidepressants are mentioned, including “brain zaps” when combined with duloxetine.
  • Unclear where the risk threshold lies; doses and individual susceptibility vary.

Anecdotal experiences

  • Multiple anecdotes: improved mood, reduced “monkey mind,” better schizoaffective or anxiety symptoms when increasing omega‑3 and/or lowering omega‑6.
  • Others report no benefit, or mixed/negative experiences.
  • Some report marked benefit from high‑EPA products specifically.

Skepticism, study design, and limits

  • Several note that many supplement benefits fade in larger trials, and that mouse results often don’t translate to humans.
  • Others argue waiting for perfect long‑term RCTs is impractical; a “kitchen‑sink” adjunctive approach is reasonable if risks are low.
  • One thread questions why mice are still used, with the reply that invasive mechanistic work (e.g., brain tissue analysis) isn’t feasible in humans.

Related threads

  • Extended side discussion on dry eye: many report little to no benefit from omega‑3; other treatments and lifestyle changes dominate that discussion.
  • Ethical concerns about massive use and suffering of lab mice are raised.
  • Broader point: effects of diet/supplements are highly individual and can be strongly shaped by genetics and specific metabolic pathways.